Association for Diagnostics and Laboratory Medicine
ADLM congressional briefing explains the importance of laboratory developed tests for pediatric care and the FDA rule that will limit access to these critical tests
LISA CEO explains why crowdfunding is a viable way to shoulder the new regulatory costs behind laboratory-developed tests
We’ve updated our Privacy Policy to make it clearer how we use your personal data. Please read our Cookie Policy to learn how we use cookies to provide you with a better experience.